SCHEMBL5862855

SCHEMBL5862855

CC(=O)NC1CCN(CCCn2cc3ccc(NC(=O)Nc4ccc(Oc5ccccc5)cc4)cc3n2)C1

nearest known ligand 0.61

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 11/20 0.61
MCHR2 Q969V1 7/20 0.49
LTA4H P09960 2/20 0.45
CXCR3 P49682 2/20 0.44
EPHX2 P34913 1/20 0.44
KCNH2 Q12809 1/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5862093 0.88 MCHR1 (0.79) MCHR1MCHR2
SCHEMBL5862829 0.86 MCHR1 (0.70) MCHR1MCHR2CXCR3KDM4ENPC1
SCHEMBL5862042 0.84 MCHR1 (0.76) MCHR1MCHR2KDM4ENPC1RAB9A
SCHEMBL5860851 0.83 MCHR1 (0.61) MCHR1MCHR2NPC1RAB9A
SCHEMBL5860833 0.83 MCHR1 (0.75) MCHR1MCHR2KDM4ENPC1RAB9A
SCHEMBL6349174 0.83 MCHR1 (0.71) MCHR1MCHR2EPHX2
SCHEMBL5860790 0.82 MCHR1 (0.70) MCHR1MCHR2KDM4ENPC1RAB9A
SCHEMBL5862060 0.82 MCHR1 (0.67) MCHR1MCHR2EPHX2
SCHEMBL5862783 0.81 MCHR1 (0.68) MCHR1MCHR2KDM4ENPC1RAB9A
SCHEMBL5862796 0.81 MCHR1 (0.59) MCHR1MCHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7049307-B2 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2006-05-23 US claimed
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-08-25 US claimed
US-20050137187-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-06-23 US claimed
US-7049307-B2 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES (US) 2006-05-23 US disclosed
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBVIE INC. 2005-08-25 US disclosed
US-20050137187-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor ABBOTT LABORATORIES 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137187-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R MCHR1 1/4885MCHR2 2/4885LTA4H 2805/4885
US-20050187279-A1 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor MCHR1, MCHR2, MC1R MCHR1 1/4885MCHR2 2/4885LTA4H 2805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.